INVECTYS, INC. TO PARTICIPATE IN THE 41st JP MORGAN HEALTHCARE CONFERENCE ON JANUARY 9-12, 2023

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Houston, Texas, Jan. 05, 2023 (GLOBE NEWSWIRE) — Invectys, Inc. “Invectys”, a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of cell therapy products for cancer patients, today announced that Praveen Tyle, Ph.D., President and CEO of Invectys, will participate in the 2023 edition of the JP Morgan Healthcare Meeting on January 9-12, 2023. In addition to the main meeting, Dr. Tyle will also attend the 2023 BIO One-on-One partnering meetings live from January 9-12 at the San Francisco Marriott Marquis.

If you would like to set up a meeting, feel free to contact us at contactus@invectys.com.

About Invectys

Invectys, transforming innovative immunotherapies to eradicate cancer, is a clinical stage immunotherapy company spun-out of the world-renowned Pasteur Institute in Paris. Invectys has two wholly owned subsidiaries, Invectys, S.A.S. (Paris) which is focused on scientific research and innovation and Invectys USA, Inc. (Houston), whose lead product is the development of a first-in-human HLAG /CAR T initiative. Invectys has raised over $68 million in private funds to develop innovative platforms of immunotherapy products. Invectys has also received a grant of $14.2 million from the Cancer Prevention and Research Institute of Texas (Grant ID DP200034) to help fund it’s lead HLA-G CAR T program.

Contact:
Invectys, Inc. – Rosie Williams
contactus@invectys.com

Staff

Recent Posts

CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for…

7 hours ago

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release…

7 hours ago

inTouch Addresses $6.7 Billion Senior Loneliness Crisis with Launch of AI Conversational Companion for North America

Complements Family Interactions & Supports Sandwich Generation of Caregivers with Daily Phone Calls to Seniors…

7 hours ago

AI in Healthcare: MENA Region on the Verge of a Major Breakthrough

"Comprehensive Analysis of MENA's AI Healthcare Market: Emerging Opportunities and Challenges, with a Projected CAGR…

7 hours ago

Global Excel Acquires First Assistance to Strengthen Assistance Services and Expand in the Asia-Pacific Market

SHERBROOKE QC, July 2, 2025 /PRNewswire/ - Global Excel Management Inc. (Global Excel) is pleased…

7 hours ago

Single Pass Inc. Launches Global Post-Market Evaluation of the Biopsy Tract Closure Device

The evaluation will include 1,000 unique procedures across 20 centers worldwide to capture real-world evidence…

13 hours ago